News and Newsletters

February 2012

BAC BV and Life Technologies launch high speed affinity HPLC columns for real-time pharmaceutical process monitoring

2011

BAC and GE Healthcare expand product offering with the addition of VIISelect Bioprocess media

BAC BV collaborates in providing custom CaptureSelect® affinity ligands for Bristol-Myers Squibb’s Adnectin™ biotherapeutics

PhyNexus and BAC BV launch full range of CaptureSelect resins in PhyTip column format

BAC BV collaborates with Life Technologies to provide new HPLC affinity columns

2010

BAC BV and BioSystem Development collaborate to bring industry-leading purification ligands to high throughput biotherapeutic process development.

BAC completes feasibility study in providing unique selective ligands for Genmab’s UniBody® platform

BAC launches CaptureSelect® HumanPlasma14 for depletion of abundant proteins from human blood plasma or serum

BAC and Octapharma extend collaboration for G-CSF custom ligand for commercial scale manufacture

BAC Affinity Ligand Licensed for Clinical and Commercial Scale-up of LFB Biotechnologies’ Recombinant Factor VIIa

BAC Extends Partnership with GE Healthcare to Launch Alpha-1 Antitrypsin Select

2009

BAC BV expands alliance with Octapharma Group for the purification of recombinant proteins

2008

BAC expands collaboration with GE Healthcare with launch of KappaSelect

BAC Secures €1.5 M Series B R&D Financing for Affinity Products

BAC and LFB to develop ligand for Purifying Recombinant Factor VIIa

BAC signs license agreement with Hematech

BAC and Octapharma to develop custom ligand for recombinant plasma protein

2007

BAC launches CaptureSelect® toolbox for antibody purification

BAC announces collaboration with Sanofi Pasteur

2006

GE healthcare and BAC announce strategic collaboration

2005

BAC BV completes financing led by FF&P Private Equity